Drug
Botulinum Toxin type a (Botox)
Botulinum Toxin type a (Botox) is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
1
25%
Ph not_applicable
2
50%
Ph phase_4
1
25%
Phase Distribution
1
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
2(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 11 (25.0%)
Phase 41 (25.0%)
N/A2 (50.0%)
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completednot_applicable
Ultrasound-Guided Botulinum Toxin A Injection for TMJ Disc Displacement With Reduction
NCT07076355
completedphase_1
Hyperhidrosis in Patients With Amputations-Botox
NCT03236012
completednot_applicable
The Therapeutic Use of Botulinum Toxin Type A in Subacute Cervical/Upper Back Pain
NCT00282958
completedphase_4
Effects of Botulinum Toxin Type A in Adults With Cerebral Palsy
NCT00432055
Clinical Trials (4)
Showing 4 of 4 trials
NCT07076355Not Applicable
Ultrasound-Guided Botulinum Toxin A Injection for TMJ Disc Displacement With Reduction
NCT03236012Phase 1
Hyperhidrosis in Patients With Amputations-Botox
NCT00282958Not Applicable
The Therapeutic Use of Botulinum Toxin Type A in Subacute Cervical/Upper Back Pain
NCT00432055Phase 4
Effects of Botulinum Toxin Type A in Adults With Cerebral Palsy
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4